Polyvinylpyrrolidone & Levothyroxine Sodium

26 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

1150.0%

Death Rate

Active Ingredients

Polyvinylpyrrolidone & Levothyroxine Sodium

Administration Routes

OralUnknown

Species Affected

Dog 26

Most Affected Breeds

Retriever - Labrador 8

Dog (unknown) 2

Retriever - Golden 2

Collie - Border 1

Terrier - Boston 1

Spaniel - Cocker American 1

Retriever - Chesapeake Bay 1

Terrier - Yorkshire 1

Bulldog 1

Chihuahua 1

Most Reported Reactions

Vomiting 6

Seizure NOS 4

Lethargy (see also Central nervous system depression in 'Neurological') 4

Panting 3

Other abnormal test result NOS 3

Elevated serum alkaline phosphatase (SAP) 3

Hypothyroidism 2

Anorexia 2

Polydipsia 2

Lymphoma 2

Death by euthanasia 2

Hives (see also 'Skin') 2

Outcome Breakdown

Ongoing

14 (53.8%)

Recovered/Normal

8 (30.8%)

Euthanized

2 (7.7%)

Outcome Unknown

1 (3.8%)

Died

1 (3.8%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.